As of Oct 12
| +1.13 / +2.08%|
The 2 analysts offering 12-month price forecasts for Cantel Medical Corp have a median target of 58.00, with a high estimate of 62.00 and a low estimate of 54.00. The median estimate represents a +4.77% increase from the last price of 55.36.
The current consensus among 2 polled investment analysts is to Buy stock in Cantel Medical Corp. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.